A wide range of products such as GHP, PVDF, and nylon! Syringe filters for UHPLC.
We would like to introduce our "0.2 μm PSF Acrodisc Syringe Filter." The free-floating pre-filter prevents early clogging. The thermally bonded 0.2 μm final membrane guarantees particle removal without breakthrough. 【Features】 ■ Wide range of product lineup (GHP, PVDF, PES, Nylon, PTFE) ■ Enhanced filtration efficiency with multi-pre-filter (GxF) ■ Compatibility guarantee for SOTAX automatic analyzers for dissolution testing ■ Low drug adsorption and low elution performance ■ Effective filtration area of 3.9 cm² in 25 mm size *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
**GxF Multi Prefilter Features** - For samples that are difficult to filter, syringe filters incorporating glass fiber prefilters with membranes are suitable. - For samples with an extremely high content of fine particles, the Acrodisc PSF syringe filter with a GxF multilayer glass fiber prefilter is suitable. - The Acrodisc syringe filter, equipped with conventional products such as GHP membranes or nylon membranes from Pall, also incorporates a single-layer glass fiber prefilter, and this product can also be used. *For more details, please refer to the PDF document or feel free to contact us.*
Price range
Delivery Time
Applications/Examples of results
【Usage】 ■ For sample pretreatment ■ For UHPLC *For more details, please refer to the PDF document or feel free to contact us.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.
